Hims & Hers director exercises 545 RSUs

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) director Christopher D. Payne reported an exercise of 545 Restricted Stock Units (RSUs) into 545 shares of Class A common stock on 2026-08-14, leaving him with 34,863 shares held directly and 110,000 shares held indirectly through The Payne Family Trust. The RSUs represent a contingent right to receive one share of Class A common stock per unit and were issued under the company’s Director Compensation Policy in lieu of the second-quarter 2026 cash retainer fee, with the $16,598 foregone fees divided by a $30.40 grant price to determine the grant amount; the RSUs will vest in full on the company’s next quarterly vesting date.

Insider Trade Summary

545 shares exercised/converted

Exercise 3 txns

Insider Payne Christopher D

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit F1	545	$0.00	$0.00
Exercise	Class A Common Stock F1	545	--	--
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Unit — 0 contracts (Direct); Class A Common Stock — 34,863 shares (Direct); Class A Common Stock — 110,000 shares (Indirect, Held by The Payne Family Trust dtd 09/17/2020)

Footnotes (1)

1. F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.

Key Figures

RSUs exercised: 545 shares Common stock acquired: 545 shares Direct holdings after transaction: 34,863 shares +3 more

6 metrics

RSUs exercised 545 shares RSUs converted into Class A common stock on 2026-08-14

Common stock acquired 545 shares Class A common stock received from RSU exercise on 2026-08-14

Direct holdings after transaction 34,863 shares Class A common stock directly owned by Christopher D. Payne after 2026-08-14

Indirect holdings via trust 110,000 shares Class A common stock held by The Payne Family Trust dtd 09/17/2020

Foregone director cash fees $16,598 Second-quarter 2026 director retainer fee converted into RSUs

RSU grant price $30.40 Grant price used to calculate the number of RSUs issued

Key Terms

Restricted Stock Units, Director Compensation Policy, contingent right, grant price

4 terms

Restricted Stock Units financial

"The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Director Compensation Policy financial

"The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy"

contingent right financial

"RSUs which represent a contingent right to receive one share of Class A Common Stock"

grant price financial

"The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Christopher D. Payne report for HIMS on this Form 4?

Christopher D. Payne reported exercising 545 Restricted Stock Units into 545 shares of Hims & Hers Health Class A common stock on 2026-08-14, reflecting a derivative exercise/conversion rather than an open-market purchase or sale.

How many HIMS shares does Christopher D. Payne hold after the reported transactions?

After the transactions, Christopher D. Payne holds 34,863 Hims & Hers Health Class A shares directly and 110,000 shares indirectly through The Payne Family Trust dtd 09/17/2020, as disclosed in the Form 4 holding entries.

How were the RSUs for Christopher D. Payne at HIMS calculated and what cash fees did they replace?

The RSU grant for Christopher D. Payne replaced $16,598 of second-quarter 2026 director cash retainer fees, calculated by dividing those foregone fees by a $30.40 grant price per share to determine the number of RSUs issued under the Director Compensation Policy.

What do the RSUs reported by Christopher D. Payne for HIMS represent?

The RSUs represent a contingent right to receive one share of Hims & Hers Health Class A common stock for each RSU, issued under the company’s Director Compensation Policy in lieu of cash fees, with full vesting on the next quarterly vesting date.

When will Christopher D. Payne’s reported RSUs in HIMS vest?

The RSUs reported for Christopher D. Payne will vest in full on Hims & Hers Health’s next quarterly vesting date, at which point each vested RSU entitles him to receive one share of Class A common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 05:03 PM EDT Accepted by SEC EDGAR 08/18/2026 - 05:03 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Payne Christopher D

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/14/2026		M		545	A	(1)	34,863	D
Class A Common Stock								110,000	I	Held by The Payne Family Trust dtd 09/17/2020

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	08/14/2026		M			545	(1)	(1)	Class A Common Stock	545	$0	0	D

Explanation of Responses:

1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Christopher D Payne	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)